News & Videos - ACCELERATE DIAGNOSTICS INC.

Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results PR Newswire TUCSON, Ariz., March 28, 2024 TUCSON, Ariz. , March 28, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended December 31, 2023 . "In 2023, we made significant progress with the development of our next-generation rapid Antibiotic Susceptibility Testing system, Accelerate Wave™. We continue to advance this important...

Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results. PR Newswire TUCSON, Ariz., March 7, 2024 TUCSON, Ariz. , March 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, March 28, 2024 , at 4:30 p.m. Eastern Time to review 2023 fourth quarter and full year results. To listen to the audio webcast online, visit ir.axdx.com . A replay of the audio webcast will be available...

Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement PR Newswire TUCSON, Ariz., Jan. 19, 2024 TUCSON, Ariz. , Jan. 19, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) (the "Company") today announced the pricing of an underwritten public offering consisting of 6,860,659 units, each consisting of one share of common stock and one warrant to purchase one share of common stock, and for certain investors in lieu thereof,...

Accelerate Diagnostics Announces Launch of Proposed Public Offering PR Newswire TUCSON, Ariz., Jan. 16, 2024 TUCSON, Ariz. , Jan. 16, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) (the "Company") today announced the launch of a proposed underwritten public offering of 4,500,000 units, each consisting of one share of common stock and one warrant to purchase one share of common stock, or for certain investors, pre-funded units in lieu thereof, with each pre-funded unit...

Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results PR Newswire TUCSON, Ariz., Jan. 7, 2024 TUCSON, Ariz. , Jan. 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing services that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections, today announced certain preliminary, unaudited results for the quarter and year ended...

Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper® PR Newswire TUCSON, Ariz., Nov. 27, 2023 Working together to bring rapid, automated microbial identification directly from positive blood culture samples TUCSON, Ariz. , Nov. 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the signing of a collaboration and quality agreement with...

Accelerate Diagnostics Reports Third Quarter 2023 Results PR Newswire TUCSON, Ariz., Nov. 9, 2023 TUCSON, Ariz. , Nov. 9, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the third quarter ended September 30, 2023 . "During the quarter we made significant advances with our Wave program," commented Jack Phillips, Chief Executive Officer of Accelerate Diagnostics, Inc. "We are getting results well within current standard of care methods to...

Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results. PR Newswire TUCSON, Ariz., Oct. 30, 2023 TUCSON, Ariz. , Oct. 30, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, November 9, 2023 , at 4:30 p.m. Eastern Time to review 2023 third quarter results. To listen to the audio webcast online, visit ir.axdx.com . A replay of the audio webcast will be available for 30 days. To listen by...

Accelerate Diagnostics Reports Second Quarter 2023 Financial Results PR Newswire TUCSON, Ariz., Aug. 10, 2023 TUCSON, Ariz. , Aug. 10, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter for the period ended June 30, 2023 . "Throughout the quarter, we've significantly advanced our Wave Program," stated Jack Phillips , CEO of Accelerate Diagnostics, Inc. "Our recent achievements underscore our commitment to delivering a Wave...

Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter Results PR Newswire TUCSON, Ariz., July 27, 2023 TUCSON, Ariz. , July 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, August 10, 2023 , at 4:30 p.m. Eastern Time to review 2023 second quarter results. To listen to the audio webcast online, visit ir.axdx.com . A replay of the audio webcast will be available for 30 days. To listen by...

Accelerate Diagnostics Announces 1-for-10 Reverse Stock Split PR Newswire TUCSON, Ariz., July 10, 2023 TUCSON, Ariz. , July 10, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc., (NASDAQ: AXDX) (the "Company") a leading provider of innovative rapid diagnostic solutions, announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10. The reverse stock split will become effective at 5:00 p.m. Eastern Time , on July 11, 2023 . The Company's...

Accelerate Diagnostics Announces Successful Completion of Debt Restructuring Support Agreement, Supporting Advancement of Next-Generation Platform Wave PR Newswire TUCSON, Ariz., June 13, 2023 TUCSON, Ariz. , June 13, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc., (NASDAQ: AXDX) a leading provider of innovative rapid diagnostic solutions, has closed the transactions contemplated by the previously announced restructuring support agreement. Through a series of transactions, the company has...

Accelerate Diagnostics Reports First Quarter 2023 Financial Results PR Newswire TUCSON, Ariz., May 11, 2023 TUCSON, Ariz. , May 11, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the first quarter for the period ended March 31, 2023 . "Our first quarter results are in line with expectations, and I am optimistic about the remainder of 2023 and beyond," commented Jack Phillips , Chief Executive Officer of Accelerate Diagnostics, Inc. "We are...

Accelerate Diagnostics scheduled call to review 2023 first quarter results PR Newswire TUCSON, Ariz., April 27, 2023 TUCSON, Ariz. , April 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, May 11, 2023 , at 4:30 p.m. Eastern Time to review 2023 first quarter results. To listen to the audio webcast online, visit ir.axdx.com . A replay of the audio webcast will be available for 30 days. To listen by phone,...

Accelerate Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results PR Newswire TUCSON, Ariz., March 29, 2023 TUCSON, Ariz. , March 29, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended December 31, 2022 . "In 2022, we achieved another year of revenue growth thanks to our base book of satisfied customers," commented Jack Phillips , Chief Executive Officer of Accelerate Diagnostics, Inc., "Though...

Accelerate Diagnostics scheduled call to review 2022 fourth quarter and full year results PR Newswire TUCSON, Ariz., March 15, 2023 TUCSON, Ariz. , March 15, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Wednesday, March 29, 2023 , at 4:30 p.m. Eastern Time to review 2022 fourth quarter and full year results. To listen to the audio webcast online, visit ir.axdx.com . A replay of the audio webcast will be available...

Accelerate Diagnostics announces departure of CFO Steve Reichling and appointment of David Patience as replacement PR Newswire TUCSON, Ariz., March 14, 2023 TUCSON, Ariz. , March 14, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) a leading provider of innovative rapid diagnostic solutions, announced today that Steve Reichling will be stepping down as Chief Financial Officer (CFO), effective March 31, 2023 . David Patience , who previously served as Senior Director - Head of...

Accelerate Diagnostics announces appointment of Hany Massarany to Chairman of Board of Directors PR Newswire TUCSON, Ariz., March 8, 2023 TUCSON, Ariz. , March 8, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) a disruptor in bloodstream infection identification and susceptibility testing today announced the appointment of Hany Massarany to chairman of the company's board of directors effective February 22, 2023 . Jack Phillips , Chief Executive Officer of Accelerate...

Accelerate Diagnostics submits 510(K) application to FDA for Gram-negative menu expansion and breakpoint updates for the Accelerate PhenoTest® BC kit PR Newswire TUCSON, Ariz., Dec. 19, 2022 TUCSON, Ariz. , Dec. 19, 2022 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced that the Company has submitted a 510(k) application to the FDA for Gram-negative menu expansion and breakpoint updates for the Accelerate PhenoTest ® BC kit. Included in the submission are additional...

Accelerate Diagnostics Reports Third Quarter 2022 Financial Results PR Newswire TUCSON, Ariz., Nov. 14, 2022 TUCSON, Ariz. , Nov. 14, 2022 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the third quarter for the period ended September 30, 2022 . "Our third quarter results were generally in line with my expectations," commented Jack Phillips, Chief Executive Officer of Accelerate Diagnostics, Inc. "While I was pleased with the significant...